Skip to content

GRAIL, Inc. GRAL Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Guardant Health logo
Guardant HealthGH
$12.72B+121%
Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$7.64B-6.9%
Immunome logo
ImmunomeIMNM
$1.9B+470%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.27B+78.0%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s enterprise value?
GRAIL, Inc. (GRAL) reported enterprise value of $2.09B in Q1 2026.
How has GRAIL, Inc.'s enterprise value changed year-over-year?
GRAIL, Inc.'s enterprise value increased by 164.2% year-over-year, from $792.76M to $2.09B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.